Skip to main content
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Anti-Inflammatory & Anti-Allergy Agents.

Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in Anti-Inflammatory & Anti-Allergy Medicinal Chemistry.

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in Anti-Inflammatory & Anti-Allergy Agents drug discovery.

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents) was previously published as Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents.

Publisher: Bentham Science Publishers

More about this publication?
Volume 9, Number 2, 2010

Articles

Oleocanthal, a Natural anti-Inflammatory Compound in Extra Virgin Olive Oil
pp. 94-100(7)
Authors: Cicerale, Sara; S.J. Keast, Russell

Favourites:
ADD

Natural Products from Mediterranean Diet: From Anti-Inflammatory Agents to Dietary Epigenetic Modulators
pp. 101-124(24)
Authors: Kontogiorgis, C.A.; Bompou, E.-M.; Ntella, M.; Berghe, W. Vanden

Favourites:
ADD

Mushrooms as a Source of Anti-Inflammatory Agents
pp. 125-141(17)
Authors: Garcia-Lafuentea, Ana; Moro, Carlos; Villares, Ana; Guillamon, Eva; A. Rostagno, Mauricio; D'Arrigo, Matilde; Alfredo Martinez, Jose

Favourites:
ADD
Favourites:
ADD

Chemoprevention of Colorectal Carcinogenesis by Natural Anti-Inflammatory Agents
pp. 150-157(8)
Authors: Yasui, Yumiko; Tanaka, Takuji

Favourites:
ADD

Prenyloxyphenylpropanoids as a Novel Class of Anti-inflammatory Agents
pp. 158-165(8)
Authors: Genovese, Salvatore; Curini, Massimo; Epifano, Francesco

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content